摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl chloro((ethoxycarbonyl)oxy)carbamate | 1310365-94-6

中文名称
——
中文别名
——
英文名称
ethyl chloro((ethoxycarbonyl)oxy)carbamate
英文别名
[Chloro(ethoxycarbonyl)amino] ethyl carbonate
ethyl chloro((ethoxycarbonyl)oxy)carbamate化学式
CAS
1310365-94-6
化学式
C6H10ClNO5
mdl
——
分子量
211.602
InChiKey
SIIMQJUDVIGSIE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    65.1
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Optimization of HNO Production from N,O-bis-Acylated Hydroxylamine Derivatives
    摘要:
    A wide range of N,O-bis-acylated hydroxylamine derivatives with chloro or arenesulfonyl leaving groups, and a related set of N-hydroxy-N-acylsulfonamides, have been synthesized and evaluated for nitroxyl (HNO) production. Mechanistic studies have revealed that the observed aqueous chemistry is more complicated than originally anticipated, and have been used to develop a new series of efficient HNO precursors (4u-4x, 7c-7d) with tunable half-lives.
    DOI:
    10.1021/ol203016c
点击查看最新优质反应信息

文献信息

  • Bis-Acylated Hydroxylamine Derivatives
    申请人:Toscano John P.
    公开号:US20110136827A1
    公开(公告)日:2011-06-09
    The invention provides certain bis-acylated hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the invention provides methods of using such compounds or pharmaceutical compositions for treating, preventing, or delaying the onset and/or develop of a disease or condition. In some embodiments, the disease or condition is selected from cardiovascular diseases, ischemia, reperfusion injury, cancerous disease, pulmonary hypertension and conditions responsive to nitroxyl therapy.
    这项发明提供了某些双酰化羟胺衍生物化合物,包括这些化合物的药物组合物和试剂盒,以及使用这些化合物或药物组合物的方法。具体而言,该发明提供了使用这些化合物或药物组合物治疗、预防或延缓疾病或病况发生和/或发展的方法。在某些实施例中,疾病或病况可选自心血管疾病、缺血、再灌注损伤、癌症疾病、肺动脉高压和对亚硝酰治疗有反应的病况。
  • US9018411B2
    申请人:——
    公开号:US9018411B2
    公开(公告)日:2015-04-28
  • US9458127B2
    申请人:——
    公开号:US9458127B2
    公开(公告)日:2016-10-04
  • Optimization of HNO Production from <i>N</i>,<i>O</i>-<i>bis</i>-Acylated Hydroxylamine Derivatives
    作者:Art D. Sutton、Morgan Williamson、Hilary Weismiller、John P. Toscano
    DOI:10.1021/ol203016c
    日期:2012.1.20
    A wide range of N,O-bis-acylated hydroxylamine derivatives with chloro or arenesulfonyl leaving groups, and a related set of N-hydroxy-N-acylsulfonamides, have been synthesized and evaluated for nitroxyl (HNO) production. Mechanistic studies have revealed that the observed aqueous chemistry is more complicated than originally anticipated, and have been used to develop a new series of efficient HNO precursors (4u-4x, 7c-7d) with tunable half-lives.
查看更多